Company Overview

Development Stage

About the Company

余仁生创立于1879年,是具有百年历史的中医药保健品牌,是亚洲知名的中药保健品牌,是被公认的中医保健业的佼佼者。产品畅销新加坡、马来西亚、印度尼西亚、澳大利亚、柬埔寨中国香港澳门等地。
余仁生国际集团在新加坡证券交易所挂牌上市,同时也是中国大陆以外*具规模的中医保健企业之一,被公认为中医保健业中的佼佼者。
百年来,我们信守初心,承袭千年中医秘方智慧,坚持天然为本、科研为证,拳拳匠心只为打造上等中药滋补,提供人人可及的天然养生保健方案,帮助人人实现*佳的生活质量。
百年来,我们在产品质量和创新科研上不断精进,由传统中草药、中成药,延伸至保健品和健康食品,用户从中老年人到儿童全年龄段覆盖。
百年来,我们不仅受到广大消费者的认可,在业界也殊荣不断,多次获得品牌大奖,在海外众多健康滋补品牌中深受消费者欢迎。
在国际化的发展道路上,余仁生已经走了140多年,在国内的余仁生中国正处于发展创造和拼搏前进的阶段。余仁生旨在成为综合保健及养生领域里值得信任的领先企业,同时继续将特有的中医药根底保存下来。
————
致每一位对余仁生感兴趣或即将成为余仁生伙伴们:
我们是一家有百年历史的中医药保健品牌,将传统中医药智慧和科学技术本源结合,为消费者提供专业的健康解决方案。
我们对品质严格把控,对顾客始终如一,对每一位努力追求目标、不断提升的伙伴都提供自我展示提升的空间以及丰厚的回报。人性化的晋升机制和薪酬体系,关注结果更关注过程。你,在我们这里一定可以找到适合你的位置,
期待你和我们一起努力奋斗,共同学习成长,创造属于我们共同的精彩
【余仁生相关自媒体账号】
官网:*
微博:余仁生健康中国
公众号:余仁生健康
小红书:余仁生
抖音:余仁生健康滋补养生专卖店

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (1 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 111%
  • 2024: Up 47%
  • 2023: Up 138%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 余仁生(杭州)生物科技有限公司 growing? 2025: 59 openings (up 111%), 2024: 28 openings (up 47%), 2023: 19 openings (up 138%), 2022: 8 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (22 records)

Manage
salary range: 4.5K - 15K, 95.4% of roles pay ¥6-15K
Note: salary statistics are based on 22 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 余仁生(杭州)生物科技有限公司?95.4% of positions earn 6-15K, Undergraduate salary: ¥。客户服务类 average salary ¥10.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 余仁生(杭州)生物科技有限公司? We provide: 运营,店长,bd,媒介,平面,摄影,主管助理,产品助理,仓库,剪辑,品牌,客服,库管,渠道,电商商务,策划,经理助理,达播商务,采购. Click to view detailed salary analysis by job.

Related Industry Tags

Job Category

  • 客户服务类
    59.1% of total 59.1%
  • 经营管理类
    27.3% of total 27.3%
  • 市场/公关/媒介类
    22.7% of total 22.7%
  • 贸易/物流/采购/运输类
    22.7% of total 22.7%

Education

  • 本科
    54.5% of total 54.5%
  • 大专
    45.5% of total 45.5%

Experience

  • 1-3年
    54.5% of total 54.5%
  • 3-5年
    27.3% of total 27.3%
  • 5-10年
    9.1% of total 9.1%
  • 不限
    9.1% of total 9.1%
View Detailed Analysis

What does 余仁生(杭州)生物科技有限公司 require? Who is 余仁生(杭州)生物科技有限公司 hiring? recruitment: 客户服务类占比最多占59.1%,其次是经营管理类占27.3%. What education can get in at ? 本科占比最多占54.5%,其次是大专占45.5%. Work experience required at ? 1-3年占比最多占54.5%,其次是3-5年占27.3%. Where are the job locations at ? 杭州占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 300万(元)
Legal Representative: 陈家全
Date Established:
Credit Code: 91330109MA2KJ1451D
Registered Address: 浙江省杭州市滨江区西兴街道联慧街88号联慧科创中心D座501、502室

People who follow this company also follow

Competitors (Similar Companies)

“涤纶工业长丝和灯箱布制造”
尿液分析 健康体检 心电监护 动态心电图机
“Global chain retailer”
“综合性汽车轴承制造企业”
“诚信,专业,服务”
酰胺 聚丙烯/PP 丙烯 聚丙烯酰胺
化工/化学 聚氨酯 树脂 聚酯/PET
“Supplier of medical care and protective products”
制药/药业 原料药 化学制药 氧氟沙星
“一家专注于电商的全域内容整合营销服务商”
文化创意 文化 文化传播 文化传媒
“A large private modern pharmaceutical distribution enterprise in China”
生物科技/生物工程 医药 药物研发 生物制剂
“合成生物学技术开发商”
洗洁精 催干剂 化学品 生产

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates